Meeting Banner
Abstract #3500

Nootropics prevent the effect of scopolamine in an phMRI provocation model

Nikolett Hegeds 1 , Pl Kocsis 2 , Dvid Gajri 2 , Szabolcs Dvid 2 , Levente Deli 2 , Zsfia Pozsgay 2 , and Kroly Tihanyi 2

1 Gedeon Richter Plc., Budapest, Hungary, 2 Gedeon Richter Plc., Hungary

The effective treatment of cognitive decline is still a major challenge of the drug research. Scopolamine based small animal phMRI provocation model can be a suitable translational method for testing new compounds. Scopolamine strongly decreased the BOLD responses in the PFC but had no visible effect in other brain areas. Scopolamines effect could be fully prevented with the donepezil pretreatment, whereas vinpocetin and piracetam caused a partial reversal of the BOLD responses only. The new vinpocetin derivative RG compound exerted partial effect also, but its effective dose was much lower than that of the reference compound donepezil.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.

Keywords